World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT00059579
Date of registration: 29/04/2003
Prospective Registration: No
Primary sponsor: National Institute of Mental Health (NIMH)
Public title: Brain Regulation of Emotions in People With Depression and Anhedonia
Scientific title: Functional MRI Study of Brain Mechanism Mediating Anhedonia in Major Depression
Date of first enrolment: April 24, 2003
Target sample size: 163
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT00059579
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
United States
Contacts
Key inclusion & exclusion criteria

- INCLUSION CRITERIA

For both patient and control groups:

Age 18 to 50 of any ethnicity without other significant medical conditions

Not in active use of illicit drugs and heavy consumption of alcohol

No metallic implants or onplants that are ferromagnetic

Competent to sign consent forms to participate in the study.

For patient groups:

For the group with significant anhedonia, current MDD, as defined by DSM-IV criteria, with
significant anhedonia defined as having PAS and/or SAS scores at or above one standard
deviation of appropriate norm. For the group without significant anhedonia, current MDD, as
defined by DSM-IV criteria, without significant anhedonia defined as having PAS and/or SAS
scores within or below one standard deviation of appropriate norm. The BPD subjects will
meet DSM-IV criteria for bipolar I or II disorder, most recent episode depressed and will
currently be in a major depressive episode. We will use the Young Mania Rating Scale to
assess the severity of the disorder Subjects may be enrolled as either inpatients or
outpatients at their entrance to the study.

For control group:

No prior history of any psychiatric conditions including substance dependence

No family history of MDD, bipolar disorder, or psychosis

PAS and/or SAS scores within or below one standard deviation of appropriate norm.

EXCLUSION CRITERIA:

Medical conditions or concomitant medications that are likely to influence cerebral blood
flow or neurological function including cardiovascular, respiratory, endocrine and
neurological diseases;

History of psychosis, current mania and substance dependence;

Exposure to psychiatric medications in the past 4 weeks;

History of repeated self-mutilation or homicidal attempts, current active suicidal /
homicidal ideations;

Current or recent (within past six weeks) illicit drug use or heavy alcohol consumption
(more than 2 six-packs of beer or equivalent alcoholic beverages per week);

Pathological gamblers as defined by DSM-IV.



Age minimum: 18 Years
Age maximum: 50 Years
Gender: All
Health Condition(s) or Problem(s) studied
Major Depressive Disorder
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
03-M-0149
030149
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history